CASE NUMBER
1:2018bk12425
1:2018bk12425
TYPE / CHAPTER
Voluntary / 11
Voluntary / 11
Docket Entries by Year
| Aug 10, 2018 | 1 | Petition Chapter 11 Voluntary Petition for Non-Individual. Order for Relief Entered. Filed by Paul V. Shalhoub of Willkie Farr & Gallagher LLP on behalf of Aralez Pharmaceuticals US Inc.. (Shalhoub, Paul) (Entered: 08/10/2018) | |
|---|---|---|---|
| Aug 10, 2018 | 2 | Motion for Joint Administration / Debtors' Motion for Order Authorizing Joint Administration Pursuant to Rule 1015(b) of the Federal Rules of Bankruptcy Procedure filed by Robin Spigel on behalf of Aralez Pharmaceuticals US Inc.. (Spigel, Robin) (Entered: 08/10/2018) | |
| Aug 10, 2018 | Receipt of Voluntary Petition (Chapter 11)(18-12425) [misc,824] (1717.00) Filing Fee. Receipt number 12714853. Fee amount 1717.00. (Re: Doc # 1) (U.S. Treasury) (Entered: 08/10/2018) | ||
| Aug 10, 2018 | 3 | Motion to Extend Deadline to File Schedules or Provide Required Information / Debtors' Motion for Order Extending Deadline for Debtors to File their Schedules of Assets and Liabilities and Statements of Financial Affairs filed by Robin Spigel on behalf of Aralez Pharmaceuticals US Inc.. (Spigel, Robin) (Entered: 08/10/2018) | |
| Aug 10, 2018 | 4 | Declaration of Michael Kaseta in Support of Chapter 11 Petitions and First Day Pleadings filed by Robin Spigel on behalf of Aralez Pharmaceuticals US Inc.. (Spigel, Robin) (Entered: 08/10/2018) | |
| Aug 10, 2018 | 5 | Motion to Appoint Prime Clerk LLC as Claims and Noticing Agent filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc.. (Shalhoub, Paul) (Entered: 08/10/2018) | |
| Aug 10, 2018 | 6 | Motion to Authorize / Debtors' Motion for Order: (A) Waiving Requirement for Filing List of Creditors; (B) Authorizing Debtors to File Consolidated List of Creditors; and (C) Authorizing Debtors to Establish Procedures for Notifying Creditors of Commencement of Cases filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc.. (Shalhoub, Paul) (Entered: 08/10/2018) | |
| Aug 10, 2018 | 7 | Motion to Authorize / Debtors' Motion for Order Pursuant to Section 105(a) of the Bankruptcy Code Enforcing Protections of Sections 362, 365, 525 and 541 of the Bankruptcy Code filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc.. (Shalhoub, Paul) (Entered: 08/10/2018) | |
| Aug 10, 2018 | 8 | Motion to Authorize / Debtors' Motion for Interim and Final Orders Authorizing: (A) Continued Use of Debtors' Cash Management System and Procedures; (B) Maintenance and Continued Use of Existing Bank Accounts; (C) Modification of Certain U.S. Trustee Operating Guidelines Relating to Bank Accounts; (D) Modification of Requirements of Section 345(b) of the Bankruptcy Code on an Interim and Final Basis; (E) Continuation of Intercompany Transactions and Accordance of Administrative Expense Status to Intercompany Claims; and (F) Granting Related Relief filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc.. (Shalhoub, Paul) (Entered: 08/10/2018) | |
| Aug 10, 2018 | 9 | Motion to Authorize / Debtors' Motion for Interim and Final Orders: (A) Authorizing Payment of Prepetition Common Carrier, Warehouse, and Related Obligations; and (B) Granting Related Relief filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc.. (Shalhoub, Paul) (Entered: 08/10/2018) | |
| Aug 10, 2018 | 10 | Motion to Authorize / Debtors' Motion Pursuant to Sections 105(a) and 363(b) of the Bankruptcy Code for Entry of Interim and Final Orders: (A) Authorizing Debtors to Pay Prepetition Claims of Certain Foreign Creditors; and (B) Granting Related Relief filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc.. (Shalhoub, Paul) (Entered: 08/10/2018) | |
| Aug 10, 2018 | 11 | Motion to Authorize / Debtors' Motion for Interim and Final Orders: (A) Authorizing Debtors to Pay (I) Prepetition Employee Wages, Salaries and Other Compensation, (II) Prepetition Employee Business Expenses, (III) Other Miscellaneous Employee Expenses and Employee Benefits; and (B) Granting Related Relief filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc.. (Shalhoub, Paul) (Entered: 08/10/2018) | |
| Aug 10, 2018 | 12 | Motion to Approve Debtor in Possession Financing / Debtors' Motion for Interim and Final Orders: (I) Authorizing Postpetition Financing; (II) Granting Liens, Security Interest and Superpriority Status; (III) Authorizing Use of Cash Collateral; (IV) Affording Adequate Protection; (V) Scheduling a Final Hearing; (VI) Modifying the Automatic Stay; and (VII) Granting Related Relief filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc.. (Shalhoub, Paul) (Entered: 08/10/2018) | |
There are 5 newer docket entries.To see the entire docket, login, subscribe now, or purchase this single case. |
|||
This case is closed and is no longer being updated.
| BROWN RUDNICK LLP |
|---|
| Buchalter, a Professional Corporation |
| Cardinal Health |
| CHIESA SHAHINIAN & GIANTOMASI PC |
| CHIESA SHAHINIAN & GIANTOMASI PC |
| COLE SCHOTZ P.C. |
| Gibson, Dunn & Crutcher LLP |
| KATTEN MUCHIN ROSENMAN LLP |
| KATTEN MUCHIN ROSENMAN LLP |
| Sirlin Lesser & Benson, P.C. |
Aralez Pharmaceuticals US Inc.
400 Alexander Park Drive
Princeton, NJ 08540
MERCER-NJ
US
Tax ID / EIN: xx-xxx6948
Paul V. Shalhoub
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019-6099
(212) 728-8764
Fax : (212) 728-8111
Email: maosbny@willkie.com
Robin Spigel
Willkie Far & Gallagher LLP
787 Seventh Avenue
New York, NY 10019-6099
212 728-8822
Fax : 212 728-8111
Email: maosbny@willkie.com
United States Trustee
Office of the United States Trustee
U.S. Federal Office Building
201 Varick Street, Room 1006
New York, NY 10014
(212) 510-0500
| Date Filed | Name = parent case |
Chapter | Case # |
|---|---|---|---|
| Feb 8, 2023 |
Big Village Group Inc.
|
11 | 1:2023bk10176 |
| Sep 24, 2021 | Princeton-Windsor Pediatrics, P.A. | 11V | 3:2021bk17501 |
| Feb 3, 2021 |
Lonestar Pipeline Company, LLC
|
11 | 4:2021bk30358 |
| Feb 3, 2021 |
Frontera Intermediate Holdings LLC
|
11 | 4:2021bk30357 |
| Feb 3, 2021 | Frontera Holdings LLC | 11 | 4:2021bk30354 |
| Feb 3, 2021 |
Frontera Generation Limited Partnership
|
11 | 4:2021bk30353 |
| Feb 3, 2021 |
Frontera Generation Holdings LLC
|
11 | 4:2021bk30356 |
| Feb 3, 2021 |
Frontera Generation GP, LLC
|
11 | 4:2021bk30355 |
| Nov 30, 2020 | Fillit, Inc. | 11 | 3:2020bk23140 |
| Jul 1, 2020 | Montage Consulting Inc | 7 | 3:2020bk18163 |
| Sep 14, 2018 | Microdermis Corporation | 7 | 4:2018bk35179 |
| Aug 10, 2018 |
POZEN Inc.
|
11 | 1:2018bk12431 |
| Aug 10, 2018 |
Halton Laboratories LLC
|
11 | 1:2018bk12430 |
| Aug 10, 2018 |
Aralez Pharmaceuticals R&D Inc.
|
11 | 1:2018bk12428 |
| Aug 10, 2018 |
Aralez Pharmaceuticals Management Inc.
|
11 | 1:2018bk12427 |
